Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of NaoXinQing Tablets in recovery-phase ischemic stroke with blood stasis obstructing the collaterals pattern
CTR20243753Phase 2Active
- Sponsor
- Guangzhou Baiyunshan Hutchison Whampoa Chinese Medicine
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NaoXinQing in ischemic stroke, sponsored by Guangzhou Baiyunshan Hutchison Whampoa Chinese Medicine. Started Sep 2024; status: active.
02
Drugs
NaoXinQing
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20243753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243753.